Cargando…
Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262491/ https://www.ncbi.nlm.nih.gov/pubmed/35796137 http://dx.doi.org/10.4111/icu.20220203 |
_version_ | 1784742507499749376 |
---|---|
author | Lee, Hye Won Seo, Ho Kyung |
author_facet | Lee, Hye Won Seo, Ho Kyung |
author_sort | Lee, Hye Won |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9262491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Urological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-92624912022-07-13 Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder Lee, Hye Won Seo, Ho Kyung Investig Clin Urol Editorial The Korean Urological Association 2022-07 2022-06-22 /pmc/articles/PMC9262491/ /pubmed/35796137 http://dx.doi.org/10.4111/icu.20220203 Text en © The Korean Urological Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Lee, Hye Won Seo, Ho Kyung Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder |
title | Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder |
title_full | Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder |
title_fullStr | Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder |
title_full_unstemmed | Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder |
title_short | Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder |
title_sort | clinical implications and practical considerations for poly-adp-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262491/ https://www.ncbi.nlm.nih.gov/pubmed/35796137 http://dx.doi.org/10.4111/icu.20220203 |
work_keys_str_mv | AT leehyewon clinicalimplicationsandpracticalconsiderationsforpolyadpribosepolymeraseinhibitorsasanewhorizonforthemanagementofurothelialcarcinomaofthebladder AT seohokyung clinicalimplicationsandpracticalconsiderationsforpolyadpribosepolymeraseinhibitorsasanewhorizonforthemanagementofurothelialcarcinomaofthebladder |